Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, double-blind, placebo-controlled trial

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1981 • 848 citations

Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo

1981 • 511 citations

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

1981 • 511 citations

Serotonin and the Cardiovascular System

1985 • 255 citations

Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist

1982 • 165 citations

Enhanced in vivo platelet “release reaction” in old healthy individuals

1980 • 115 citations

Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.

1989 • 104 citations

Evidence for functional 5-HT2 receptor sites on human blood platelets

1984 • 102 citations

Rapid, Sensitive Microassay for Platelet 5HT

1974 • 90 citations

9th international symposium on atherosclerosis

1991 • 61 citations

Blood Cells and Arteries in Hypertension and Atherosclerosis

1989 • 60 citations

Blood platelets in human essential hypertension

1986 • 55 citations

Enhanced Platelet Release Reaction, Shortened Platelet Survival Time and Increased Platelet Aggregation and Plasma Thromboxane B2 in Chronic Obstructive Arterial Disease

1985 • 53 citations

Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets

1983 • 39 citations

β-thromboglobulin in plasma; false high values caused by platelet enrichment of the top layer of plasma during centrifugation

1979 • 38 citations

Antihypertensive Action and Serotonin-Induced Platelet Aggregation During Long-Term Ketanserin Treatment in Hypertensive Patients

1984 • 36 citations

Evaluation of Some Platelet Parameters in a Group of Elderly People

1981 • 35 citations

Influence of Lysolecithin on Platelet Aggregation initiated by 5-Hydroxytryptamine

1973 • 31 citations

Platelet activation during treadmill exercise in patients with chronic peripheral arterial disease

1981 • 24 citations

Ketanserin in Intermittent Claudication

1987 • 22 citations

Platelet Serotonin in Essential Hypertension and in Mental Depression

1985 • 22 citations

The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases

1985 • 21 citations

The appearance of exhausted platelets due to a duration of hypertension in stroke-prone spontaneously hypertensive rats

1985 • 20 citations

Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human plateletsin vitro

1986 • 18 citations

Continuous Inhibition of Platelet S2-Serotonergic Receptors During Chronic Administration of Ketanserin in Humans

1985 • 18 citations

Standardization of β-Thromboglobulin (β-TG) and Platelet Factor 4 (PF4): A Collaborative Study to Establish International Standards for β-TG and PF4

1985 • 18 citations

Blood Pressure, 5-OH Indoleacetic Acid, and Vanilmandelic Acid Excretion and Blood Platelet Aggregation in Hypertensive Patients Treated with Ketanserin

1985 • 16 citations

Platelets and Antiplatelet Therapy in Ischemic Heart Disease

1988 • 16 citations

THE EFFECT OF KETANSERIN IN ESSENTIAL HYPERTENSION

1983 • 12 citations

Potentiation of vasoconstrictor responses to serotonin in the limb of atherosclerotic monkeys.

1986 • 11 citations

Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH

1985 • 9 citations

Continuous inhibition of the platelet S2-serotonergic receptors during the long term administration of ketanserin

1986 • 9 citations

Platelet survival, atherosclerotic intermittent claudication and ticlopidine

1984 • 5 citations

Continuous Inhibition of Serotonin-Induced Platelet Aggregation during Chronic Ketanserin Administration to Man Can Be Detected after Plasma pH Control

1987 • 5 citations